S. Kecel-Gunduz Et Al. , "In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles," DARU, Journal of Pharmaceutical Sciences , vol.28, pp.139-157, 2020
Kecel-Gunduz, S. Et Al. 2020. In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles. DARU, Journal of Pharmaceutical Sciences , vol.28 , 139-157.
Kecel-Gunduz, S., Budama-Kilinc, Y., Çakır Koç, R., Zorlu, T., Bicak, B., Kokcu, Y., ... Ozel, A.(2020). In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles. DARU, Journal of Pharmaceutical Sciences , vol.28, 139-157.
Kecel-Gunduz, Serda Et Al. "In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles," DARU, Journal of Pharmaceutical Sciences , vol.28, 139-157, 2020
Kecel-Gunduz, Serda K. Et Al. "In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles." DARU, Journal of Pharmaceutical Sciences , vol.28, pp.139-157, 2020
Kecel-Gunduz, S. Et Al. (2020) . "In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles." DARU, Journal of Pharmaceutical Sciences , vol.28, pp.139-157.
@article{article, author={Serda KECEL GÜNDÜZ Et Al. }, title={In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles}, journal={DARU, Journal of Pharmaceutical Sciences}, year=2020, pages={139-157} }